Want to see IN:BODALCHEM full AI Analyst Report?
Top Page
Bodal Chemicals Limited
(BODALCHEM)
Select Model
Select Model
Rating:64Neutral
Price Target:
₹71.00
▲(31.34% Upside)
Action:Reiterated
Date:05/23/26
The score is led by strong technical momentum and an inexpensive P/E valuation, but held back by only moderate financial quality—particularly the history of uneven free cash flow and meaningful leverage despite the FY2026 operating and FCF improvement.
Positive Factors
Revenue recovery & growth
Sustained top-line rebound across FY2025–FY2026 indicates renewed demand or better realizations in core dye and intermediates markets. A growing revenue base supports durable cash generation and scale benefits, improving the outlook for margin recovery and reinvestment over coming quarters.
Negative Factors
High leverage
Meaningful and rising debt increases interest and refinancing risk and constrains strategic flexibility. With leverage elevated relative to prior periods, downturns in margins or cash flow could quickly stress coverage metrics and limit the company's ability to invest or return capital.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue recovery & growth
Sustained top-line rebound across FY2025–FY2026 indicates renewed demand or better realizations in core dye and intermediates markets. A growing revenue base supports durable cash generation and scale benefits, improving the outlook for margin recovery and reinvestment over coming quarters.
Read all positive factors
Bodal Chemicals Limited (BODALCHEM) vs. iShares MSCI India ETF (INDA)
Market Cap
₹8.40B
Dividend YieldN/A
Average Volume (3M)9.69K
Price to Earnings (P/E)17.4
Beta (1Y)1.37
Revenue Growth15.32%
EPS Growth158.73%
CountryIN
Employees2,133
SectorBasic Materials
Sector Strength58
IndustryChemicals - Specialty
Share Statistics
EPS (TTM)2.81
Shares Outstanding125,944,060
10 Day Avg. Volume13,655
30 Day Avg. Volume9,685
Financial Highlights & Ratios
PEG Ratio0.09
Price to Book (P/B)0.56
Price to Sales (P/S)0.32
P/FCF Ratio8.67
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)7.1
Revenue Forecast (FY)₹22.23B
Bodal Chemicals Limited Business Overview & Revenue Model
Company Description
Bodal Chemicals Limited, an Indian enterprise, produces and supplies a range of chemicals, including dyestuffs, dye intermediates, and various other chemical products. Its comprehensive portfolio of dye intermediates features key compounds such as...
How the Company Makes Money
Bodal Chemicals makes money mainly by manufacturing and selling chemical products, with revenue generated from (1) dyes and (2) dye intermediates sold to industrial customers. Its earnings are driven by sales volumes and realizations (selling pric...
Bodal Chemicals Limited Financial Statement Overview
Summary
Income Statement
62
Positive
Balance Sheet
55
Neutral
Cash Flow
48
Neutral
| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 18.29B | 20.12B | 17.45B | 13.95B | 15.63B | 20.27B |
| Gross Profit | 8.38B | 7.04B | 6.76B | 1.68B | 6.70B | 5.42B |
| EBITDA | 1.89B | 1.68B | 1.69B | 1.19B | 1.45B | 2.16B |
| Net Income | 354.45M | 478.28M | 185.02M | 64.69M | 380.33M | 1.04B |
Balance Sheet | ||||||
| Total Assets | 23.13B | 23.56B | 23.53B | 22.88B | 21.21B | 21.22B |
| Cash, Cash Equivalents and Short-Term Investments | 391.00M | 579.69M | 360.60M | 462.50M | 225.87M | 93.95M |
| Total Debt | 8.66B | 8.13B | 9.11B | 8.47B | 6.98B | 5.76B |
| Total Liabilities | 11.91B | 11.98B | 12.48B | 12.06B | 10.43B | 10.70B |
| Stockholders Equity | 11.22B | 11.58B | 11.05B | 10.82B | 10.78B | 10.56B |
Cash Flow | ||||||
| Free Cash Flow | 587.21M | 743.38M | -83.36M | -407.19M | -528.49M | -1.73B |
| Operating Cash Flow | 778.82M | 1.10B | 381.14M | 2.04B | 2.85B | -135.20M |
| Investing Cash Flow | 75.41M | -13.37M | -424.34M | -2.62B | -3.10B | -1.70B |
| Financing Cash Flow | -920.92M | -1.14B | 76.36M | 809.81M | 326.55M | 1.81B |
Bodal Chemicals Limited Technical Analysis
Negative
54.06
Price Trends
69.39
Negative
60.07
Positive
58.76
Positive
Market Momentum
-0.68
Positive
44.97
Neutral
34.70
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:BODALCHEM, the sentiment is Negative. The current price of 54.06 is below the 20-day moving average (MA) of 68.97, below the 50-day MA of 69.39, and below the 200-day MA of 58.76, indicating a neutral trend. The MACD of -0.68 indicates Positive momentum. The RSI at 44.97 is Neutral, neither overbought nor oversold. The STOCH value of 34.70 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:BODALCHEM.
Bodal Chemicals Limited Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ₹9.53B | 20.85 | ― | 0.81% | 46.98% | 14.03% | |
68 Neutral | ₹8.25B | 0.18 | ― | 0.45% | -31.13% | 3690.43% | |
65 Neutral | ₹12.94B | 18.36 | ― | 0.52% | 21.13% | 18.86% | |
64 Neutral | ₹8.40B | 17.40 | ― | ― | 15.32% | 158.73% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
56 Neutral | ₹25.19B | 0.42 | ― | ― | -8.84% | 1863.82% | |
52 Neutral | ₹8.02B | 149.69 | ― | 1.07% | -14.55% | -74.70% |
* Basic Materials Sector Average
IN:BODALCHEM
Bodal Chemicals Limited
66.70
-10.15
-13.21%
IN:AGARIND
Agarwal Industrial Corporation Limited
551.30
-441.96
-44.50%
IN:BHAGERIA
Bhageria Industries Ltd.
218.35
10.50
5.05%
IN:FAIRCHEMOR
Fairchem Organics Ltd
637.00
-359.88
-36.10%
IN:KIRIINDUS
Kiri Industries Limited
386.55
-187.95
-32.72%
IN:SHREEPUSHK
Shree Pushkar Chemicals & Fertilisers Ltd.
400.05
61.50
18.17%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.